| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $63.5M | -83.2% |
| R&D Expense | $367.6M | -16.0% |
| SG&A Expense | $111.5M | -4.5% |
| Operating Income | -$415.6M | -135.5% |
| Pre-tax Income | -$376.7M | -187.2% |
| Income Tax | $39K | -97.1% |
| Net Income | -$376.7M | -184.3% |
| EPS (Basic) | -$4.58 | -166.3% |
| EPS (Diluted) | -$4.58 |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $282.0M | -35.3% |
| Current Assets | $878.1M | -27.5% |
| Total Assets | $1.10B | -24.4% |
| Current Liabilities | $182.1M | -11.4% |
| Total Liabilities | $370.3M | -22.6% |
| Stockholders' Equity | $733.5M | -25.2% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$347.2M | -132.7% |
| Capital Expenditures | $8.9M | -73.5% |
| Investing Cash Flow | $185.0M | +157.5% |
| Financing Cash Flow | $7.7M | -97.2% |
| Free Cash Flow | -$356.2M | -94.7% |
| -166.3% |